COMP <GO>
PGNY vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Progyny Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: PGNY 4
— MRK 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PGNY
LAST: $29.19 (+2.78%) • MKT CAP: $2.18B
balance-sheet
8.84
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGNY VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PGNY | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.60% | 74.80% | -51.20 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.70% | 20.70% | -4.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.5x | 15.3x | +5.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 8.80% | 3.42% | +5.38 | PGNY | /fcf-yield <GO> |
| Operating Margin | 6.60% | 34.30% | -27.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 28.10% | -23.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 10.40% | 1.30% | +9.10 | PGNY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.84 | 5.19 | +3.65 | PGNY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 51.7 | +3.40 | PGNY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 18.4x | +16.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.18B | $361.02B | -$358.84B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PGNY REV | MRK REV | PGNY GROSS % | MRK GROSS % | PGNY FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.29B | $65.01B | 23.6% | 74.8% | $191.8M | $12.36B |
| FY 2024 | $1.17B | $64.17B | 21.7% | 76.3% | $173.7M | $18.10B |
| FY 2023 | $1.09B | $60.12B | — | — | $188.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGNY // BETA —
MRK // BETA 0.92